GlobeNewswire

Forterra Announces Fourth Quarter and Full Year 2018 Results

Del

Fourth Quarter and Full Year 2018 Highlights

  • Gross profit margin improved to 17.3% for the quarter and 16.6% for the year, compared to 15.6% and 16.0%, respectively, in the prior year periods
  • Income from operations increased by $9 million for the quarter and $49 million for the full year, compared to 2017
  • Adjusted EBITDA margins1 of 9.7% for the quarter and 11.4% for the year were both above the prior year periods of 8.1% and 9.6%, respectively

Full Year 2019 Outlook

  • Full-year 2019 guidance targeting income from operations in the range of $60 to $90 million, net loss of $38 million to $16 million and Adjusted EBITDA of $170 to $200 million
  • Majority of available cash flow is expected to be used to initiate voluntary repayment of the term loan of $30 million to $85 million

1 A reconciliation of non-GAAP financial measures to comparable GAAP financial measures is provided in the Reconciliation of Non-GAAP Measures section of this press release.

IRVING, Texas, March 11, 2019 (GLOBE NEWSWIRE) -- Forterra, Inc. (“Forterra” or “the Company”) (NASDAQ: FRTA), a leading manufacturer of water and drainage infrastructure pipe and products in the United States and Eastern Canada, today announced results for the quarter and full year ended December 31, 2018.

CEO Commentary
Forterra CEO Jeff Bradley commented, “We delivered higher year over year gross profit margins, income from operations and Adjusted EBITDA margins for both the quarter and the full year on the benefit of higher selling prices, our cost control programs and increased operational efficiency.  We were pleased to deliver earnings improvement in 2018 in spite of record levels of rainfall in certain of our key regions."

Mr. Bradley continued. "We believe we are well positioned to deliver further earnings improvement and positive cash flow in 2019 against the backdrop of solid market demand fundamentals. We anticipate continued earnings growth in Drainage in 2019 on the benefit of growing infrastructure demand. In Water, we expect the actions taken in the second half of 2018 to position us for margin expansion in 2019."

Fourth Quarter 2018 Results
Fourth quarter 2018 net sales were $339.2 million, compared to $361.2 million in the prior year quarter. Net loss for the quarter was $17.0 million, or $0.27 per share, compared to net income of $43.2 million, or $0.67 per share, in the prior year quarter. Net income in the prior year quarter included the benefit of a $45.4 million reduction in the Company's Tax Receivable Agreement liability as described in the Corporate results below. Adjusted EBITDA for the fourth quarter was up 12.2% to $32.9 million, compared to $29.3 million in the prior year quarter.

Drainage Pipe & Products (“Drainage”) - Fourth Quarter 2018 Results
Drainage net sales were $190.0 million, compared to $204.6 million in the prior year quarter. Excluding net sales from divestitures of $9.6 million, net sales declined by approximately 3% due to shipment delays as a result of significant rain.

Drainage gross profit and gross profit margin increased to $41.1 million and 21.6%, compared to $35.4 million and 17.3%, respectively, in the prior year quarter. The increase in gross profit and gross profit margin was due to higher average selling prices, the benefit of cost control initiatives and lower rent expense. Fourth quarter 2018 Drainage EBITDA and Adjusted EBITDA increased to $33.9 million and $33.8 million, respectively, compared to $30.8 million and $32.5 million, respectively, in the prior year quarter.

Water Pipe & Products (“Water”) - Fourth Quarter 2018 Results
Water net sales were $149.2 million, compared to $156.6 million in the prior year quarter.  The decline in net sales was due to lower volumes resulting from significant rain.

Water gross profit in the fourth quarter was $17.8 million compared to $22.0 million in the prior year quarter. Fourth quarter 2018 Water EBITDA and Adjusted EBITDA of $15.6 million and $15.9 million, respectively, compared to $16.7 million and $18.0 million, respectively, in the prior year quarter.  The declines in gross profit, EBITDA and Adjusted EBITDA were due to the impact of higher scrap costs for ductile iron pipe that were not fully offset by an increase in selling prices. The gross profit decline was also due to lower net sales of concrete pressure pipe in Canada.

Corporate and Other (“Corporate”) - Fourth Quarter 2018 Results
Corporate EBITDA loss of $18.3 million and Adjusted EBITDA loss of $16.8 million in Q4 2018 compared to EBITDA of $21.8 million and Adjusted EBITDA loss of $21.1 million, respectively, in the prior year quarter. Corporate EBITDA in Q4 2017 included the benefit of a $45.4 million reduction in the Company's Tax Receivable Agreement liability due to the benefit of U.S. tax reform under the Tax Cuts and Jobs Act. Excluding this one-time benefit, the improved results in Corporate were due primarily to lower professional fees, including reduced audit fees and fees related to external consultants associated with the Company’s Sarbanes-Oxley compliance and material weakness remediation work. Corporate costs were higher than the guidance due to incremental work required in the fourth quarter to remediate the material weakness related to the Company's information technology systems that was identified during the quarter. As noted below, the Company successfully completed the remediation of all of its previously reported material weaknesses.

Full Year 2018 Results
Full year 2018 net sales were $1,479.7 million, compared to $1,580.4 million in the prior year, with the decrease as a result of divestitures. The divestiture of the U.S. concrete and steel pressure pipe business in July 2017 resulted in a $72.7 million decline in net sales. The Foley Exchange, completed in January 2018, resulted in a $42.3 million decline in net sales. Excluding the impact of these two transactions, net sales increased by 1.0%, due primarily to higher average selling prices.

Gross profit and gross profit margin were $245.6 million and 16.6%, respectively, compared to $253.1 million and 16.0%, respectively, in the prior year. Income from operations increased to $51.0 million, compared to $2.4 million in the prior year. Net loss for the year was $24.4 million, or a loss of $0.38 per share, compared to a net loss of $2.1 million, or a loss of $0.03 per share, in the prior year.  The prior year period included a pre-tax benefit of $46.2 million due to a reduction in the tax receivable agreement liability and a $40.7 million income tax benefit, both due primarily to U.S. tax reform.  The prior year benefits from U.S. tax reform were partially offset by a $32.5 million loss due to the divestiture of the U.S. concrete and steel pressure pipe business. Adjusted EBITDA for the year was $168.7 million, compared to $151.8 million in the prior year.  Drainage EBITDA and Adjusted EBITDA were $156.7 and $159.7 million, respectively, compared to $129.6 and $137.1 million in the prior year.  The $22.6 million increase in Drainage Adjusted EBITDA was due primarily to higher average selling prices that more than offset the impact of increased costs including raw materials, labor and freight.  Water EBITDA and Adjusted EBITDA were $64.5 million and $66.9 million, respectively, compared to $47.6 million and $93.8 million in the prior year.  Water Adjusted EBITDA decreased by $26.9 million due primarily to steel scrap, labor and freight costs that were not fully offset by higher average selling prices.  Corporate EBITDA and Adjusted EBITDA loss were $58.8 million and $57.9 million, respectively, compared to $44.9 million and $79.1 million in the prior year.  Corporate Adjusted EBITDA loss improved by $21.2 million due primarily to lower professional fees, including lower audit fees and lower fees relating to the Company’s Sarbanes-Oxley compliance and material weakness remediation work.

Balance Sheet and Liquidity
On December 31, 2018, the Company had cash of $35.8 million and outstanding debt on its senior term loan of $1.2 billion.  As of December 31, 2018, there was no outstanding balance on the Company's $300 million Revolver.  Cash flow from operations for the year was $15.1 million lower than the prior year due primarily to an increase in working capital, partially offset by higher earnings after adjusting for non-cash income and expenses.  Change in assets and liabilities was a cash use of $39.4 million compared to a cash use of $57.6 million in the prior year period.  Excluding the impact of changes in tax-related receivables and payables that resulted in a cash inflow of $12.8 million in 2018 and a cash outflow of $43.3 million in 2017, the change in assets and liabilities in 2018 was a cash use of $52.2 million, compared to a cash use of $14.3 million in the prior year, due primarily to an increase in ending inventory.  The increase in inventory was due to weather-related shipment delays as well as a strategic decision to accelerate the normal seasonal build in inventory of ductile iron pipe to support customers.  Cash interest paid of $69.4 million was $14.7 million higher than the prior year due to $8.5 million in payments associated with the sale leaseback agreement as well as the impact of higher average interest rates.  Cash taxes of $11.1 million were $17.0 million lower than the prior year due primarily to the benefit of a $20.0 million tax refund pertaining to the 2017 tax year.

Remediation of Previously Reported Material Weaknesses
The Company completed the remediation of previously reported material weaknesses in the internal control over financial reporting, including the material weakness related to the Company's information technology systems that was identified in the fourth quarter of 2018.  Management's Report on Internal Control over Financial Reporting, included in our Annual Report on Form 10-K that is expected to be filed with the SEC effective March 12, 2019, includes a more detailed discussion of the matter.

2019 Outlook
The Company expects the full year 2019 net loss will be in the range of $38 to $16 million and Adjusted EBITDA in the range of $170 million to $200 million.  The Company anticipates continued strong execution in Drainage and margin improvement in Water on the benefit of higher selling prices and operational improvements.  The Company's end-market demand outlook supports its expectation for top-line growth.

Key Components of Expected 2019 Cashflows:

($ in millions) Low   High
Cash Interest $(82)   $(80)
Capital Expenditures (50)   (45)
TRA Payments (12)   (11)
Cash Taxes (10)   (16)
Principal Amortization (13)   (13)
Working Capital 30   50
Total $(137)   $(115)

Forterra CEO Jeff Bradley commented, "We believe market demand for our products is strong, and I am encouraged by conversations with our customers about the anticipated level of activity this year that support our outlook.  The first quarter, our seasonally weakest period of the year, has been impacted by above average rainfall, snow and abnormally cold temperatures in many of our key markets.  In addition to weather, we believe that the first quarter will be impacted by higher year over year steel and scrap costs in both businesses.  We therefore expect that our full year forecasted growth will be weighted towards the back half of the year."

Mr. Bradley continued, "Our forecast for 2019 cash flow items reflects our disciplined approach to cash management.  We are committed to strengthening our capital structure through a combination of earnings growth, debt repayment and prudent investment in the business. We expect to generate meaningful available cash flow in 2019 and plan to use a significant portion  to make voluntary repayments on our term loan."

Drainage - Key Financial and Operational Statistics:

($ in millions)   Fourth Quarter   Full Year
                     
        Q4 2018   Q4 2017   2018   2017
                     
Net Sales   $ 190.0     $ 204.6     $ 811.5     $ 834.8  
Gross Profit   41.1     35.4     174.8     147.7  
EBITDA   33.9     30.8     156.7     129.6  
Adjusted EBITDA   $ 33.8     $ 32.5     $ 159.7     $ 137.1  
Gross Profit Margin 21.6 %   17.3 %   21.5 %   17.7 %
Adjusted EBITDA Margin 17.8 %   15.9 %   19.7 %   16.4 %
                     

Water - Key Financial and Operational Statistics:

($ in millions)   Fourth Quarter   Full Year
                     
        Q4 2018   Q4 2017   2018   2017
                     
Net Sales   $ 149.2     $ 156.6     $ 668.2     $ 745.6  
Gross Profit   17.8     22.0     71.5     108.3  
EBITDA   15.6     16.7     64.5     47.6  
Adjusted EBITDA   $ 15.9     $ 18.0     $ 66.9     $ 93.8  
Gross Profit Margin 11.9 %   14.0 %   10.7 %   14.5 %
Adjusted EBITDA Margin 10.7 %   11.5 %   10.0 %   12.6 %
                     

Conference Call and Webcast Information
Forterra will host a conference call to review fourth quarter and full year 2018 results on March 12, 2019 at 10:00 a.m. Eastern Time (9:00 a.m. Central Time). The dial-in number for the call is 574-990-1396 or toll free 844-498-0572. The participant passcode is 8297545. Please dial in at least five minutes prior to the call to register. The call may also be accessed via a webcast that is available on the Investors section of the Company’s website at http://forterrabp.com.  A replay of the conference call will be available for 30 days under the Investor section of the Company's website.

About Forterra
Forterra is a leading manufacturer of water and drainage pipe and products in the U.S. and Eastern Canada for a variety of water-related infrastructure applications, including water transmission, distribution, drainage and storm water management. Based in Irving, Texas, Forterra’s product breadth and significant scale help make it a one-stop shop for water related pipe and products, and a preferred supplier to a wide variety of customers, including contractors, distributors and municipalities. For more information on Forterra, visit http://forterrabp.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements may be identified by the use of words such as "anticipate", "believe", "expect", "estimate", "plan", "outlook", and "project" and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results will be achieved. Forward-looking statements are based on historical information available at the time the statements are made and are based on management's reasonable belief or expectations with respect to future events, and are subject to risks and uncertainties, many of which are beyond the Company's control, that could cause actual performance or results to differ materially from the belief or expectations expressed in or suggested by the forward-looking statements. Forward-looking statements speak only as of the date on which they are made and the Company undertakes no obligation to update any forward-looking statement to reflect future events, developments or otherwise, except as may be required by applicable law.

Investors are referred to the Company's filings with the Securities and Exchange Commission, including its Annual Report on Form 10-K, for additional information regarding the risks and uncertainties that may cause actual results to differ materially from those expressed in any forward-looking statement, including additional information regarding risks and uncertainties relating to the level of construction activity, particularly in the residential construction and non-residential construction markets; government funding of infrastructure and related construction activities; the highly competitive nature of our industry and our ability to effectively compete; the availability and price of the raw materials we use in our business; the ability to implement our growth strategy; our dependence on key customers and the absence of long-term agreements with these customers; the level of construction activity in Texas; energy costs; disruption at one or more of our manufacturing facilities or in our supply chain; construction project delays and our inventory management; our ability to successfully integrate acquisitions; labor disruptions and other union activity; a tightening of mortgage lending or mortgage financing requirements; our current dispute with HeidelbergCement related to the payment of an earnout; compliance with environmental laws and regulations; compliance with health and safety laws and regulations and other laws and regulations to which we and our products are subject; our dependence on key executives and key management personnel; our ability to retain and attract additional skilled and non-skilled technical or sales personnel; credit and non-payment risks of our customers; warranty and related claims; legal and regulatory claims; the seasonality of our business and its susceptibility to adverse weather; our contract backlog; our ability to maintain sufficient liquidity and ensure adequate financing or guarantees for large projects; delays or outages in our information technology systems and computer networks; security breaches in our information technology systems and other cybersecurity incidents; and additional factors discussed in our filings with the Securities and Exchange Commission, or the SEC.


FORTERRA, INC.
Consolidated Statements of Operations
(in thousands, except per share data)

  Quarter ended   Year ended
  December 31,   December 31,
  2018 2017   2018 2017
  unaudited unaudited    
Net sales $ 339,155   $ 361,169     $ 1,479,712   $ 1,580,413  
Cost of goods sold 280,400   304,731     1,234,143   1,327,305  
Gross profit 58,755   56,438     245,569   253,108  
Selling, general & administrative expenses (58,260 ) (63,070 )   (209,877 ) (255,034 )
Impairment and exit charges (445 ) (216 )   (4,336 ) (13,220 )
Earnings from equity method investee 2,417   2,911     10,162   12,360  
Other operating income, net 2,659   (54 )   9,523   5,197  
  (53,629 ) (60,429 )   (194,528 ) (250,697 )
Income (loss) from operations 5,126   (3,991 )   51,041   2,411  
           
Other income (expenses)          
Interest expense (25,344 ) (13,206 )   (78,337 ) (59,408 )
Change in tax receivable agreement liability   45,440       46,180  
Other income (expense), net   (309 )   6,016   (31,915 )
Income (loss) before income taxes (20,218 ) 27,934     (21,280 ) (42,732 )
Income tax (expense) benefit 3,266   15,224     (3,085 ) 40,672  
Net income (loss) $ (16,952 ) $ 43,158     $ (24,365 ) $ (2,060 )
           
Basic and diluted earnings (loss) per share:          
Net income (loss) $ (0.27 ) $ 0.67     $ (0.38 ) $ (0.03 )
           
Weighted average common shares outstanding:          
Basic 63,965   63,824     63,904   63,801  
Diluted 63,965   63,952     63,904   63,801  


FORTERRA, INC.
Consolidated Balance Sheets
(in thousands)

  December 31,
  2018   2017
ASSETS      
Current assets      
Cash and cash equivalents $ 35,793     $ 104,534  
Receivables, net 198,468     192,654  
Inventories 285,030     236,655  
Prepaid expenses 7,289     5,381  
Other current assets 17,509     27,059  
Current assets held for sale     12,242  
Total current assets 544,089     578,525  
Non-current assets      
Property, plant and equipment, net 492,167     412,572  
Goodwill 508,193     496,141  
Intangible assets, net 183,789     225,304  
Investment in equity method investee 50,607     54,445  
Other long-term assets 14,407     18,866  
Non-current assets held for sale     25,385  
Total assets $ 1,793,252     $ 1,811,238  
LIABILITIES AND EQUITY      
Current liabilities      
Trade payables $ 114,708     $ 108,560  
Accrued liabilities 70,236     72,782  
Deferred revenue 9,138     9,029  
Current portion of long-term debt 12,510     12,510  
Current portion of tax receivable agreement 15,457     34,601  
Current liabilities held for sale     4,615  
Total current liabilities 222,049     242,097  
Non-current liabilities      
Long-term debt 1,176,095     1,181,277  
Long-term capital leases 134,948     4,155  
Deferred tax liabilities 46,615     67,481  
Deferred gain on sale-leaseback 9,338     75,743  
Other long-term liabilities 22,667     25,032  
Long-term tax receivable agreement 73,318     82,962  
Total liabilities 1,685,030     1,678,747  
Commitments and Contingencies      
Equity      
Common stock, $0.001 par value. 190,000 shares authorized; 64,206 and 64,231 shares issued and outstanding at December 31, 2018 and December 31, 2017, respectively 18     18  
Additional paid-in-capital 234,931     230,023  
Accumulated other comprehensive loss (10,740 )   (5,098 )
Retained deficit (115,987 )   (92,452 )
Total shareholders' equity 108,222     132,491  
Total liabilities and shareholders' equity $ 1,793,252     $ 1,811,238  


FORTERRA, INC.
Consolidated Statements of Cash Flows
(in thousands)

  Year ended
December 31,
  2018   2017
CASH FLOWS FROM OPERATING ACTIVITIES      
Net loss $ (24,365 )   $ (2,060 )
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation & amortization expense 105,423     115,659  
(Gain) / loss on business divestiture (6,016 )   32,278  
(Gain) / loss on disposal of property, plant and equipment (4,266 )   2,107  
Amortization of debt discount and issuance costs 8,143     8,123  
Stock-based compensation expense 6,240     3,696  
Impairment on property, plant, and equipment and goodwill 956     10,551  
Earnings from equity method investee (10,162 )   (12,360 )
Distributions from equity method investee 13,141     13,717  
Unrealized gain on derivative instruments, net (1,408 )   (5,251 )
Unrealized foreign currency gains, net (527 )   (615 )
Provision (recoveries) for doubtful accounts (1,224 )   2,947  
Deferred income taxes (20,768 )   (25,496 )
Tax receivable agreement non-cash items     (46,180 )
Deferred rent 1,373     2,616  
Other non-cash items 83     196  
Change in assets and liabilities:      
Receivables, net (2,466 )   (16,831 )
Inventories (45,313 )   1,838  
Other current assets 8,657     (24,003 )
Accounts payable and accrued liabilities (4,548 )   (19,424 )
Other assets & liabilities 4,243     826  
NET CASH PROVIDED BY OPERATING ACTIVITIES 27,196     42,334  
CASH FLOWS FROM INVESTING ACTIVITIES      
Purchase of property, plant and equipment, and intangible assets (50,609 )   (52,514 )
Proceeds from business divestiture 618     23,200  
Proceeds from sale of fixed assets 8,429      
Settlement of net investment hedges (4,990 )    
Assets and liabilities acquired, business combinations, net (4,500 )   (36,709 )
NET CASH USED IN INVESTING ACTIVITIES (51,052 )   (66,023 )
CASH FLOWS FROM FINANCING ACTIVITIES      
Payment of debt issuance costs     (2,498 )
Payments on senior term loan (12,510 )   (12,008 )
Proceeds from senior term loan, net     200,000  
Proceeds from revolver     194,000  
Payments on revolver     (293,000 )
Payment pursuant to tax receivable agreement (30,407 )    
Other financing activities (534 )   (244 )
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES (43,451 )   86,250  
Effect of exchange rate changes on cash (1,434 )   1,949  
Net change in cash and cash equivalents (68,741 )   64,510  
Cash and cash equivalents, beginning of period 104,534     40,024  
Cash and cash equivalents, end of period $ 35,793     $ 104,534  


Additional Statistics
(unaudited)

Reconciliation of Non-GAAP Measures

In addition to our results calculated under generally accepted accounting principles in the United States ("GAAP"), in this earnings release we also present adjusted EBITDA and adjusted EBITDA margin. Adjusted EBITDA and adjusted EBITDA margin are non-GAAP measures and have been presented in this earnings release as supplemental measures of financial performance that are not required by, or presented in accordance with GAAP.  We calculate adjusted EBITDA as net income (loss) before net interest expense, depreciation and amortization, income tax (expense) benefit, and before loss (gain) on sale of property, plant and equipment, impairment and exit charges, transaction costs, inventory step-up impacting margins, loss on business divestitures, non-cash compensation and certain other income and expenses, such as the change in the tax receivable agreement liability. Adjusted EBITDA margin represents adjusted EBITDA as a percentage of net sales.  Prior period amounts have been adjusted to reflect the current period calculation of adjusted EBITDA.

Adjusted EBITDA and adjusted EBITDA margin are presented in this earnings release because they are important metrics used by management as one of the means by which it assesses our financial performance. Adjusted EBITDA and adjusted EBITDA margin are also frequently used by analysts, investors and other interested parties to evaluate companies in our industry. We use adjusted EBITDA and adjusted EBITDA margin as supplements to GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, to allocate resources and to compare our performance relative to our peers. Adjusted EBITDA and adjusted EBITDA margin are also important measures for assessing our operating results and evaluating each operating segment’s performance on a consistent basis, by excluding the impacts of depreciation, amortization, income tax expense, interest expense and other items not indicative of ongoing operating performance. Additionally, these measures, when used in conjunction with related GAAP financial measures, provide investors with additional financial analytical framework that management uses, in addition to historical operating results, as the basis for financial, operational and planning decisions and present measurements that third parties have indicated are useful in assessing the Company and its results of operations.

Adjusted EBITDA and adjusted EBITDA margin have certain limitations. Adjusted EBITDA should not be considered as an alternative to consolidated net income (loss), and in the case of our segment results, adjusted EBITDA should not be considered an alternative to EBITDA, which the CODM reviews for purposes of evaluating segment profit, or in the case of any of the non-GAAP measures, as a substitute for any other measure of financial performance calculated in accordance with GAAP. Similarly, adjusted EBITDA margin should not be considered as an alternative to gross margin or any other margin calculated in accordance with GAAP.  These measures also should not be construed as an inference that our future results will be unaffected by unusual or nonrecurring items for which these non-GAAP measures make adjustments. Additionally, adjusted EBITDA and adjusted EBITDA margin are not intended to be liquidity measures because of certain limitations such as: (i) they do not reflect our cash outlays for capital expenditures or future contractual commitments; (ii) they do not reflect changes in, or cash requirements for, working capital; (iii) they do not reflect interest expense, or the cash requirements necessary to service interest, or principal payments, on indebtedness; (iv) they do not reflect income tax expense or the tax necessary to pay income taxes; and (v) although depreciation and amortization are non-cash charges, the assets being depreciated and amortized will often have to be replaced in the future, and these non-GAAP measures do not reflect cash requirements for such replacements.

Other companies, including other companies in our industry, may not use such measures or may calculate one or more of the measures differently than as presented in this earnings release, limiting their usefulness as a comparative measure. In evaluating adjusted EBITDA and adjusted EBITDA margin, you should be aware that in the future we will incur expenses that are the same as or similar to some of the adjustments made in the calculations below and the presentation of adjusted EBITDA and adjusted EBITDA margin should not be construed to mean that our future results will be unaffected by such adjustments. Management compensates for these limitations by using adjusted EBITDA and adjusted EBITDA margin as supplemental financial metrics and in conjunction with results prepared in accordance with GAAP.


FORTERRA, INC.
Reconciliation of net income (loss) to adjusted EBITDA
(in thousands)

  Three months ended December 31,   Year ended December 31,
  2018   2017   2018   2017
  unaudited   unaudited        
Net income (loss) $ (16,952 )   $ 43,158     $ (24,365 )   $ (2,060 )
Interest expense 25,344     13,206     78,337     59,408  
Depreciation and amortization 26,053     28,196     105,423     115,659  
Income tax (benefit) expense (3,266 )   (15,224 )   3,085     (40,672 )
EBITDA1 31,179     69,336     162,480     132,335  
(Gain) loss on sale of property, plant & equipment, net2 (1,820 )   358     (4,267 )   2,107  
Impairment and exit charges3 445     216     4,336     13,220  
Transaction costs4 298     1,452     2,541     7,743  
Inventory step-up impacting margin5     282     464     2,433  
Loss on business divestitures6     672         32,278  
Non-cash compensation7 1,652     1,008     6,240     3,696  
Change in tax receivable agreement liability8     (45,440 )       (46,180 )
Other (gains) losses9     360     (6,688 )   (117 )
Earnings from equity method investee 10 (2,417 )   (2,911 )   (10,162 )   (12,360 )
Pro-rata share of Adjusted EBITDA from equity method investee 11 3,553     3,995     13,751     16,666  
Adjusted EBITDA $ 32,890     $ 29,328     $ 168,695     $ 151,821  
Adjusted EBITDA margin 9.7 %   8.1 %   11.4 %   9.6 %
Gross profit 58,755     56,438     245,569     253,108  
Gross profit margin 17.3 %   15.6 %   16.6 %   16.0 %


1 For purposes of evaluating segment profit, the Company's chief operating decision maker reviews EBITDA as a basis for making the decisions to allocate resources and assess performance.
2 (Gain) loss on sale of property, plant and equipment, primarily related to the disposition of manufacturing facilities.
3 Impairment of goodwill and long-lived assets and other exit and disposal costs.
4 Legal, valuation, accounting, advisory and other costs related to business combinations and other transactions.
5 Effect of the purchase accounting step-up in the value of inventory to fair value recognized in cost of goods sold as a result of business combinations.
6 Loss on divestiture of U.S. concrete and steel pressure pipe business, net of specific items for which adjustments are separately made elsewhere in the calculation of adjusted EBITDA presented herein.
7 Non-cash equity compensation expense.
8 Adjustments to the estimated value of the tax receivable agreement due primarily to the December 2017 Tax Cuts and Jobs Act.
9 Other (gains) losses, including the non-cash gain on a divestiture transaction completed in January 2018 and gains on insurance proceeds related to the destruction of property.
10 Net income from Forterra's 50% ownership in the Concrete Pipe & Precast LLC ("CP&P") joint venture accounted for under the equity method of accounting. Prior to the quarter ended September 30, 2018, Forterra did not adjust for this item in its calculation of Adjusted EBITDA.
11 Adjusted EBITDA from Forterra's 50% ownership in the CP&P joint venture. Calculated as CP&P net income adjusted primarily to add back Forterra's pro-rata portion of CP&P's depreciation and amortization and interest expense.  Prior to the quarter ended September 30, 2018, Forterra did not adjust for this item in its calculation of Forterra's Adjusted EBITDA.


FORTERRA, INC.
Reconciliation of segment EBITDA to segment adjusted EBITDA
(in thousands)

For the three months ended December 31, 2018: Drainage Pipe & Products   Water Pipe & Products   Corporate and Other   Total
EBITDA1 $ 33,894     $ 15,624     $ (18,339 )   $ 31,179  
               
(Gain) loss on sale of property, plant & equipment, net2 (2,179 )   344     15     (1,820 )
Impairment and exit charges3 153     292         445  
Transaction costs4         298     298  
Inventory step-up impacting margin5              
Loss on divestitures6              
Non-cash compensation7 410     50     1,192     1,652  
Other (gains) losses9 401     (401 )        
Earnings from equity method investee 10 (2,417 )           (2,417 )
Pro-rata share of Adjusted EBITDA from equity method investee 11 3,553             3,553  
Adjusted EBITDA $ 33,815     $ 15,909     $ (16,834 )   $ 32,890  
Adjusted EBITDA margin 17.8 %   10.7 %   NM     9.7 %
               
Net sales $ 189,951     $ 149,204     $     $ 339,155  
Gross profit $ 41,078     $ 17,831     $ (154 )   $ 58,755  


For the three months ended December 31, 2017: Drainage Pipe & Products   Water Pipe & Products   Corporate and Other   Total
EBITDA1 $ 30,786     $ 16,706     $ 21,844     $ 69,336  
               
Loss on sale of property, plant & equipment, net2 19     339         358  
Impairment and exit charges3     216         216  
Transaction costs4         1,452     1,452  
Inventory step-up impacting margin5 282             282  
Loss on divestitures6     672         672  
Non-cash compensation7 257     34     717     1,008  
Change in tax receivable agreement liability8         (45,440 )   (45,440 )
Other (gains) losses9 29         331     360  
Earnings from equity method investee 10 (2,911 )           (2,911 )
Pro-rata share of Adjusted EBITDA from equity method investee 11 3,995             3,995  
Adjusted EBITDA $ 32,457     $ 17,967     $ (21,096 )   $ 29,328  
Adjusted EBITDA margin 15.9 %   11.5 %   NM     8.1 %
               
Net sales $ 204,610     $ 156,556     $ 3     $ 361,169  
Gross profit $ 35,418     $ 21,993     $ (973 )   $ 56,438  


FORTERRA, INC.
Reconciliation of segment EBITDA to segment adjusted EBITDA
(in thousands)

For the year ended December 31, 2018: Drainage Pipe & Products   Water Pipe & Products   Corporate and Other   Total
EBITDA1 $ 156,735     $ 64,547     $ (58,802 )   $ 162,480  
               
(Gain) loss on sale of property, plant & equipment, net2 (5,598 )   1,316     15     (4,267 )
Impairment and exit charges3 1,886     2,458     (8 )   4,336  
Transaction costs4         2,541     2,541  
Inventory step-up impacting margin5 464             464  
Non-cash compensation7 1,695     256     4,289     6,240  
Change in tax receivable agreement liability8              
Other (gains) losses9 920     (1,671 )   (5,937 )   (6,688 )
Earnings from equity method investee 10 (10,162 )           (10,162 )
Pro-rata share of Adjusted EBITDA from equity method investee 11 13,751             13,751  
Adjusted EBITDA $ 159,691     $ 66,906     $ (57,902 )   $ 168,695  
Adjusted EBITDA margin 19.7 %   10.0 %   NM     11.4 %
               
Net sales $ 811,477     $ 668,235     $     $ 1,479,712  
Gross profit $ 174,786     $ 71,471     $ (688 )   $ 245,569  


For the year ended December 31, 2017: Drainage Pipe & Products   Water Pipe & Products   Corporate and Other   Total
EBITDA1 $ 129,618     $ 47,587     $ (44,870 )   $ 132,335  
               
Loss on sale of property, plant & equipment, net2 15     2,092         2,107  
Impairment and exit charges3 (14 )   12,395     839     13,220  
Transaction costs4         7,743     7,743  
Inventory step-up impacting margin5 2,433             2,433  
Loss on divestitures6     32,278         32,278  
Non-cash compensation7 711     379     2,606     3,696  
Change in tax receivable agreement liability8         (46,180 )   (46,180 )
Other (gains) losses9 29     (942 )   796     (117 )
Earnings from equity method investee 10 (12,360 )           (12,360 )
Pro-rata share of Adjusted EBITDA from equity method investee 11 16,666             16,666  
Adjusted EBITDA $ 137,098     $ 93,789     $ (79,066 )   $ 151,821  
Adjusted EBITDA margin 16.4 %   12.6 %   NM     9.6 %
               
Net sales $ 834,810     $ 745,555     $ 48     $ 1,580,413  
Gross profit $ 147,741     $ 108,320     $ (2,953 )   $ 253,108  


1 For purposes of evaluating segment profit, the Company's chief operating decision maker reviews EBITDA as a basis for making the decisions to allocate resources and assess performance.
2 (Gain) loss on sale of property, plant and equipment, primarily related to the disposition of manufacturing facilities.
3 Impairment of goodwill and long-lived assets and other exit and disposal costs.
4 Legal, valuation, accounting, advisory and other costs related to business combinations and other transactions.
5 Effect of the purchase accounting step-up in the value of inventory to fair value recognized in cost of goods sold as a result of business combinations.
6 Loss on divestiture of U.S. concrete and steel pressure pipe business, net of specific items for which adjustments are separately made elsewhere in the calculation of adjusted EBITDA presented herein.
7 Non-cash equity compensation expense.
8 Adjustments to the estimated value of the tax receivable agreement due primarily to the December 2017 Tax Cuts and Jobs Act.
9 Other (gains) losses, including the non-cash gain on a divestiture transaction completed in January 2018 and gains on insurance proceeds related to the destruction of property.
10 Net income from Forterra's 50% ownership in the CP&P joint venture accounted for under the equity method of accounting. Prior to the quarter ended September 30, 2018, Forterra did not adjust for this item in its calculation of Adjusted EBITDA.
11 Adjusted EBITDA from Forterra's 50% ownership in the CP&P joint venture. Calculated as CP&P net income adjusted primarily to add back Forterra's pro-rata portion of CP&P's depreciation and amortization and interest expense.  Prior to the quarter ended September 30, 2018, Forterra did not adjust for this item in its calculation of Forterra's Adjusted EBITDA.


FORTERRA, INC.
Reconciliation of Net Income to Adjusted EBITDA Guidance for Full Year 2019
(in millions)

    FY 2019 Adjusted EBITDA Guidance
    Low   High
Net Loss   $ (38 )   $ (16 )
Interest expense   90     92  
Income tax expense   10     16  
Depreciation and amortization   104     104  
Other EBITDA adjustments   4     4  
Adjusted EBITDA   $ 170     $ 200  


Source: Forterra, Inc.

Company Contact Information:

David J. Lawrence
Vice President of Treasury and Investor Relations
469-299-9113
IR@forterrabp.com

 

Om GlobeNewswire

GlobeNewswire
GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://globenewswire.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Følg saker fra GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra GlobeNewswire

Blackhawks, Flyers, Sabres and Lightning Headline the 2019 NHL Global Series21.3.2019 15:34:00 CETPressemelding

Chicago Blackhawks and Philadelphia Flyers to Open Regular Season in Prague, Czech Republic on Oct. 4 Buffalo Sabres and Tampa Bay Lightning to Face Off in a Pair of Games in Stockholm, Sweden on Nov. 8 and Nov. 9 2019 NHL Global Series Challenge to feature Blackhawks vs. Eisbären Berlin on Sept. 29 in Berlin, Germany and Flyers vs. Lausanne HC on Sept. 30 in Lausanne, Switzerland Tickets to Games in Berlin, Prague and Stockholm Available for Purchase on Wednesday, March 27; Tickets to Game in Lausanne Available for Purchase on Wednesday, April 10 NEW YORK/TORONTO, March 21, 2019 (GLOBE NEWSWIRE) -- The National Hockey League (NHL) and the National Hockey League Players’ Association (NHLPA), in conjunction with Live Nation Sweden, today announced that the Buffalo Sabres, Chicago Blackhawks, Philadelphia Flyers and Tampa Bay Lightning will participate in the 2019 NHL Global Series. The Chicago Blackhawks and Philadelphia Flyers will play their 2019-20 season-opening game against each ot

Farmako: World's Largest Import Contract for Pharmaceutical Cannabis21.3.2019 15:10:00 CETPressemelding

German Farmako secures 50 tonnes of flowers and oils from Polish company Pharmacann Polska FRANKFURT, March 21, 2019 (GLOBE NEWSWIRE) -- Farmako will import 50 tonnes of pharmaceutical cannabis from Pharmacann Polska into the European market over the next four years. This provides the basis for a reliable supply of pharmaceutical cannabis for millions of patients in the European healthcare system. The company expects a total revenue of several hundred million Euros from the agreed exclusive partnership. Founded in September 2018, Farmako now has grown to 40 employees and is distributing high-quality pharmaceutical cannabis to German pharmacies since March 2019. This is the biggest Cannabis contract to date, and the first big contract without participation of a Canadian LP. Farmako has signed an exclusive and binding agreement to import and distribute 50 tons of pharmaceutical cannabis over four years. Farmako and Pharmacann Polska enter strategic partnership to develop custom tailored

NexOptic Appoints Rich Geruson, Former Lexmark CEO, to Board of Directors21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- NexOptic Technology Corp. ("NexOptic" or the "Company") (TSX VENTURE: NXO) (OTCQX: NXOPF) (FRANKFURT: E3O1) is pleased to announce that Richard J. (Rich) Geruson has joined its Board of Directors, effective immediately. Mr. Geruson’s experience spans CEO roles at Lexmark International, Phoenix Technologies and VoiceSignal Technologies, and Senior Vice President and executive positions at Nokia, IBM, Toshiba, and McKinsey & Co. As CEO of Lexmark International, a multibillion-dollar imaging technology and solutions company with 10,000 employees, he grew printer sales faster than at any time in the preceding 10 years while simultaneously executing extensive process reengineering, transforming the business from negative EBITDA and high debt to positive multi-hundred-million-dollar EBITDA and a healthy debt profile. While CEO of Phoenix Technologies, he achieved consistently high profit year-over-year for six years straight in

Standard Lithium Announces Closing of $11.4 Million Bought Deal Including Partial Exercise of Over-Allotment Option21.3.2019 14:00:00 CETPressemelding

VANCOUVER, British Columbia, March 21, 2019 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLL) (OTCQX: STLHF) (FRA: S5L) is pleased to announce that it has closed its previously announced bought deal offering (the “Offering”), including the partial exercise of the over-allotment option. A total of 11,390,500 units (the “Units”) of the Company were issued at a price of $1.00 per Unit for gross proceeds of $11,390,500. Each Unit is comprised of one common share and one-half of one common share purchase warrant of the Company (each whole common share purchase warrant, a “Warrant”). Each Warrant is exercisable to acquire one common share of the Company at an exercise price of $1.30 per share, subject to adjustment in certain events, until March 21, 2022. The Units were offered and sold by way of a short form prospectus filed in each of the provinces of ‎Canada, excluding Quebec, and offered and sold elsewhere outside of Canada on a private placement

Crown Bioscience to Present Latest Advancements in Preclinical and Translational Platforms at AACR Annual Meeting 201921.3.2019 13:30:00 CETPressemelding

15 posters present data from novel models to evaluate new cancer therapeutics SAN DIEGO, March 21, 2019 (GLOBE NEWSWIRE) -- Crown Bioscience, a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces the presentation of 15 scientific posters at the American Association for Cancer Research (AACR) Annual Meeting in Atlanta, GA from March 29 to April 3. The scientific posters highlight the latest advancements in CrownBio’s integrated oncology and immuno-oncology platforms built on the world’s largest and unique experimental model libraries, including patient-derived xenografts (PDXs), innovative humanized mouse models, GEMM, syngeneic mouse tumor homografts, PDX derived organoids (PDXO), and uniquely developed analytic methods. Featured posters will present data from novel models that enable detailed evaluation of new cancer therapeutics, including targeted cancer i

Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimer’s Disease21.3.2019 12:00:00 CETPressemelding

Independent data monitoring committee advises aducanumab unlikely to meet primary endpoints, leading to decision to discontinue the trials CAMBRIDGE, Mass., March 21, 2019 (GLOBE NEWSWIRE) -- Biogen (Nasdaq: BIIB) and Eisai, Co., Ltd. (Tokyo, Japan) today announced the decision to discontinue the global Phase 3 trials, ENGAGE and EMERGE, designed to evaluate the efficacy and safety of aducanumab in patients with mild cognitive impairment due to Alzheimer’s disease and mild Alzheimer’s disease dementia. The decision to stop the trials is based on results of a futility analysis conducted by an independent data monitoring committee, which indicated the trials were unlikely to meet their primary endpoint upon completion. The recommendation to stop the studies was not based on safety concerns. “This disappointing news confirms the complexity of treating Alzheimer’s disease and the need to further advance knowledge in neuroscience. We are incredibly grateful to all the Alzheimer’s disease pa